AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 45 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $100,000 | -2.0% | 683,551 | +0.1% | 0.00% | – |
| Q3 2019 | $102,000 | -6.4% | 683,164 | +0.2% | 0.00% | – |
| Q2 2019 | $109,000 | -28.8% | 681,925 | -12.4% | 0.00% | – |
| Q1 2019 | $153,000 | -72.1% | 778,850 | -0.7% | 0.00% | – |
| Q4 2018 | $548,000 | -43.1% | 784,147 | +0.1% | 0.00% | – |
| Q3 2018 | $963,000 | +11.6% | 783,145 | +0.6% | 0.00% | – |
| Q2 2018 | $863,000 | -41.9% | 778,372 | +5.3% | 0.00% | – |
| Q1 2018 | $1,485,000 | +66.9% | 738,879 | -0.4% | 0.00% | – |
| Q4 2017 | $890,000 | -4.4% | 741,716 | +0.4% | 0.00% | – |
| Q3 2017 | $931,000 | -5.6% | 738,624 | -0.3% | 0.00% | – |
| Q2 2017 | $986,000 | -73.7% | 740,705 | -63.3% | 0.00% | – |
| Q1 2017 | $3,754,000 | +41611.1% | 2,018,863 | +118656.6% | 0.00% | – |
| Q4 2016 | $9,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 155,000 | $206,000 | 0.12% |
| Birchview Capital, LP | 128,000 | $170,000 | 0.09% |
| CARL DOMINO INC | 43,273 | $58,000 | 0.07% |
| NORTHERN CAPITAL MANAGEMENT LLC | 106,050 | $141,000 | 0.05% |
| ELEMENT CAPITAL MANAGEMENT LLC | 124,423 | $165,000 | 0.03% |
| Baker Brothers Advisors | 1,618,089 | $2,152,000 | 0.02% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $32,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 31,390 | $42,000 | 0.02% |
| WHITE PINE CAPITAL LLC | 20,000 | $27,000 | 0.01% |
| LMR Partners LLP | 112,265 | $149,000 | 0.01% |